Australia's largest stock trading and investment forum Australia's #1 stock forum

POH

Click for more information

0.00%

0.0¢ progress 2023-2 trust

If patents were contractual agreements POH would be in the...

First 6 Last

Share
Profile

Follow
playez

3,221 Posts.

18

20/06/17

16:37

Post #: 25385631
Share

Originally posted by hottod ↑

So does this also mean that the active ingredients listed on page 2 could contain both the additional Terumo formulations and injectables?

My guess is that the list is likely to contain the 4? injectables that POH has been developing in-house. The patent list certainly covers a wide range of drug types – antibiotics, chemotherapies, HIV drugs, immunosuppressants, antihypertensives, antiarrythmics, anticonvulsants, antifungals, antipsychotics, anti-anxiety drugs, hormonal treatments, bone care, Vitamin K, etc…

My further guess is that the two additional Terumo formulations are likely not in the list. My understanding from what the Company has said in the past is that the additional Terumo formulations are not injectables. What has been clearly stated is that they are for pain. There is only one pain drug I can see in the list, and it’s for migraines.

I’m very glad to see this patent covering TPM injectables. Thanks Mike senior.

Expand

If patents were contractual agreements POH would be in the ASX200 !!

POH Price at posting: 1.4¢ Sentiment: Hold Disclosure: Not Held
9 Upvote

0 Great analysis

Reply

Top Stories

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

HotCopper Highlights: Your most watched stocks for Week 47, 2024

LPE

Sales growth pushes Lovisa's fortunes (and shares) upwards

SIG

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

There are more pages in this discussion • 125 more messages in this thread...

First 6 Last

Add POH (ASX) to my watchlist

SPONSORED BY